(Q44071363)

29 November 2017

Cerebral metabolic changes in early multiple system atrophy: a PET study (English)

1 reference

29 November 2017

multiple system atrophy

1 reference

Takayuki Taniwaki

1

1 reference

29 November 2017

Makoto Nakagawa

2

1 reference

29 November 2017

Takeshi Yamada

3

1 reference

29 November 2017

Tsuyoshi Yoshida

4

1 reference

29 November 2017

Yasumasa Ohyagi

5

1 reference

29 November 2017

Masayuki Sasaki

6

1 reference

29 November 2017

Yasuo Kuwabara

7

1 reference

29 November 2017

Shozo Tobimatsu

8

1 reference

29 November 2017

Jun-ichi Kira

9

1 reference

29 November 2017

1 August 2002

1 reference

Journal of the Neurological Sciences

29 November 2017

1 reference

29 November 2017

200

1 reference

29 November 2017

1-2

1 reference

29 November 2017

79-84

1 reference

Somatic and autonomic function in progressive autonomic failure and multiple system atrophy

29 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900151-X

Multiple system atrophy--the nature of the beast

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900151-X

The striatonigral degenerations. Putaminal pigments and nosology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900151-X

Striatonigral degeneration. A clinicopathological study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900151-X

Degenerative diseases of the nervous system associated with autonomic failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900151-X

Ultrastructural studies of olivopontocerebellar atrophy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900151-X

Olivopontocerebellar degeneration. Clinical and ultrastructural abnormalities.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900151-X

Patterns of cerebral glucose metabolism detected with positron emission tomography differ in multiple system atrophy and olivopontocerebellar atrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900151-X

Differentiating between multiple system atrophy and Parkinson's disease by positron emission tomography with 18F-dopa and 18F-FDG.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900151-X

Glucose metabolism in the cortical and subcortical brain structures in multiple system atrophy and Parkinson's disease: a positron emission tomographic study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900151-X

Clinical/metabolic correlations in multiple system atrophy. A fludeoxyglucose F 18 positron emission tomographic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900151-X

Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. The Consensus Committee of the American Autonomic Society and the American Academy of Neurology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900151-X

Motor dysfunction in olivopontocerebellar atrophy is related to cerebral metabolic rate studied with positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900151-X

International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900151-X

Prospective evaluation of clinical characteristics of orthostatic hypotension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900151-X

Cerebral blood flow, oxygen and glucose metabolism with PET in progressive supranuclear palsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900151-X

Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: Validation of method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900151-X

The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900151-X

Striatal 18F-dopa uptake and brain glucose metabolism by PET in patients with syndrome of progressive ataxia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900151-X

Computed tomography, magnetic resonance imaging and positron emission tomography with [18F] fluorodeoxyglucose in multiple system atrophy and pure autonomic failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900151-X

Multiple system atrophy: a review of 203 pathologically proven cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900151-X

Multiple system atrophy with severe involvement of the motor cortical areas and cerebral white matter.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900151-X

Striatal hypometabolism distinguishes striatonigral degeneration from Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900151-X

Positron emission tomography studies on the dopaminergic system and striatal opioid binding in the olivopontocerebellar atrophy variant of multiple system atrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900151-X

10.1016/S0022-510X(02)00151-X

7 January 2021

Identifiers

DOI

1 reference

29 November 2017

1 reference